BlackRock Institutional Trust Company, N.A. - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 148 filers reported holding NOVAVAX INC in Q4 2016. The put-call ratio across all filers is 1.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of NOVAVAX INC
ValueSharesWeighting
Q4 2016$9,593,000
-31.3%
7,613,524
+13.5%
0.00%
-50.0%
Q3 2016$13,955,000
-70.7%
6,709,352
+2.5%
0.00%
-75.0%
Q2 2016$47,586,000
+40.0%
6,545,554
-0.6%
0.01%
+33.3%
Q1 2016$33,991,000
-38.5%
6,587,352
-0.0%
0.01%
-33.3%
Q4 2015$55,290,000
+15.4%
6,589,958
-2.8%
0.01%
+12.5%
Q3 2015$47,919,000
-32.8%
6,777,862
+5.8%
0.01%
-27.3%
Q2 2015$71,335,000
+32.9%
6,403,488
-1.3%
0.01%
+37.5%
Q1 2015$53,671,000
+39.0%
6,489,822
-0.3%
0.01%
+33.3%
Q4 2014$38,618,000
+39.3%
6,512,387
-2.1%
0.01%
+20.0%
Q3 2014$27,732,000
-5.2%
6,650,277
+5.1%
0.01%0.0%
Q2 2014$29,245,000
+14.0%
6,330,055
+11.8%
0.01%
+25.0%
Q1 2014$25,644,000
-4.5%
5,660,879
+7.9%
0.00%
-20.0%
Q4 2013$26,862,000
+97.2%
5,246,421
+21.3%
0.01%
+66.7%
Q3 2013$13,624,000
+51.3%
4,325,145
-1.5%
0.00%
+50.0%
Q2 2013$9,003,0004,391,4850.00%
Other shareholders
NOVAVAX INC shareholders Q4 2016
NameSharesValueWeighting ↓
BB BIOTECH AG 8,330,000$10,496,0000.39%
Alden Global Capital LLC 640,500$807,0000.28%
Quantitative Investment Management, LLC 3,784,100$4,767,0000.12%
Eventide Asset Management 1,449,700$1,827,0000.12%
Bellevue Group AG 325,000$410,0000.08%
Virtus ETF Advisers LLC 196,162$247,0000.07%
Rock Springs Capital Management LP 820,000$1,033,0000.07%
Quantbot Technologies LP 462,250$582,0000.06%
Traynor Capital Management, Inc. 43,361$55,0000.04%
Tekla Capital Management LLC 571,000$719,0000.03%
View complete list of NOVAVAX INC shareholders